Efficacy of azithromycin 1% ophthalmic solution for treatment of ocular surface disease from posterior blepharitis

Clinical and Experimental Optometry

Volumn 94, Issue 2, 2011, Pages 200-206

  Opitz, Dominick L ^a,b   Tyler, Keith F ^a  

^a ILLINOIS COLLEGE OF OPTOMETRY   (United States)

^b Midwest Eye Professionals   (United States)

Author keywords

Azithromycin; Blepharitis; Dry eye syndrome; Eyelid disease; Meibomian glands

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; EYE DROPS;

ADULT; AGED; ARTICLE; BLEPHARITIS; CLINICAL TRIAL; DRUG EFFECT; DRY EYE; FEMALE; HUMAN; LACRIMAL FLUID; MALE; MEIBOMIAN GLAND; MIDDLE AGED; PATHOPHYSIOLOGY; SECRETION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BLEPHARITIS; DRY EYE SYNDROMES; FEMALE; HUMANS; MALE; MEIBOMIAN GLANDS; MIDDLE AGED; OPHTHALMIC SOLUTIONS; TEARS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79951979737     PISSN: 08164622     EISSN: 14440938     Source Type: Journal    
DOI: 10.1111/j.1444-0938.2010.00540.x     Document Type: Article

References (47)

1. Henriquez A, Korb DR. Meibomian glands and contact lens wear. Br J Ophthalmol 1981; 65: 108-111.
2. McCulley JP, Dougherty JM, Deneau DG. Chronic Blepharitis: Classification and mechanisms. Immunol Abstsr 1981; 55-72.
3. McCulley JP, Dougherty JM, Deneau DG. Classification of chronic blepharitis. Ophthalmology 1982; 89: 1173-1180.
4. Dougherty JM, McCulley JP. Tear lysozyme measurements in chronic blepharitis. Ann Ophthalmol 1985; 17: 53-57.
5. Dougherty JM, McCulley JP, Meyer DR. Keratoconjunctivitis sicca and tear lysozyme in chronic blepharitis. In: Holley FJ, ed. The Preocular Tear Film. Lubbock, Texas: Dry Eye Institute, 1984. pp. 176-181.
6. Bowman RW, Dougherty JM, and McCulley JP. Chronic blepharitis and dry eyes. Int Ophthalmol Clin 1987; 27: 27-35.
7. Jester JV, Nicolaides N, Smith RE. Meibomian gland dysfunction. I. Keratin protein expression in normal human and rabbit meibomian glands. Invest Ophthalmol Vis Sci 1989; 30: 927-935.
8. Jester JV, Nicolaides N, Kiss-Palvolgy I, Smith RE. Meibomian gland dysfunction. II. The role of keratinization in a rabbit model of MGD. Invest Ophthalmol Vis Sci 1989; 30: 936-945.
9. Nicolaides N, Santos EC, Smith RE, Jester JV. Meibomian gland dysfunction. III. Meibomian gland lipids. Invest Ophthalmol Vis Sci 1989; 30: 946-951.
10. Bron AJ, Tiffany JM. The contribution of meibomian disease to dry eye. Ocul Surf 2004; 2: 149-165.
11. Foulks GN, Bron AJ. Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading. Ocul Surf 2003; 1: 107-126.
12. Driver PJ, Lemp MA. Meibomian gland dysfunction. Surv Ophthalmol 1996; 40: 343-367.
13. Dougherty JM, McCulley JP. Comparative bacteriology of chronic blepharitis. Br J Ophthalmol 1984; 68: 524-528.
14. McCulley JP, Dougherty JM. Bacterial aspects of chronic blepharitis. Trans Ophthalmol Soc UK 1986; 105: 314-318.
15. Kellum RE. Acne vulgarus: Studies in pathogenesis: Relative irritancy of free fatty acids from C2 to CM. Arch Dermatol 1968; 97: 722-726.
16. Shine WE, McCulley JP. Role of wax ester fatty alcohols in chronic blepharitis. Invest Ophthalmol Vis Sci 1993; 34: 3515-3521.
17. McCulley JP, Shine WE. Meibomian gland function and the tear lipid layer. Ocul Surf 2003; 1: 97-106.
18. Jackson WB. Blepharitis: current strategies for diagnosis and management. Can J Ophthalmol 2008; 43: 170-179.
19. Shine WE, McCulley JP. Polar lipids in human meibomian gland secretions. Curr Eye Res 2003; 26: 89-94.
20. Shine WE, McCulley JP. Keratoconjunctivitis sicca associated with meibomian secretion polar lipid abnormality. Arch Ophthalmol 1998; 116: 849-852.
21. Hom MM, Martinson JR, Knapp LL, Paugh JR. Prevalence of meibomian gland dysfunction. Optom Vis Sci 1990; 67: 710-712.
22. Ong BL, Larake JR. Meibomian gland dysfunction: some clinical, biochemical and physical observations. Ophthalmic Physiol Opt 1990; 10: 144-148.
23. Ong BL. Relationship between contact lens wear and meibomian gland dysfunction. Optom Vis Sci 1996; 73: 208-210.
24. Romero JM, Biser SA, Perry HD, Levinson DH, Doshi SJ, Terraciano A, Donnenfeld ED. Conservative treatment of meibomian gland dysfunction. Eye Contact Lens 2004; 30: 14-19.
25. Olson MC, Korb DR, Greiner JV. Increase in tear film lipid layer thickness following treatment with warm compresses in patients with meibomian gland dysfunction. Eye Contact Lens 2003; 29: 96-99.
26. Frucht-Pery J, Sagi E, Hemo I, Ever-Hadani P. Efficacy of doxycycline and tetracyclines in ocular rosacea. Am J Ophthalmol 1993; 116: 88-92.
27. Dougherty JM, McCulley JP, Silvany RE, Meyer DR. The role of tetracycline in chronic blepharitis. Inhibition of lipase production in staphylococci. Invest Ophthalmol Vis Sci 1991; 32: 2970-2975.
28. Pinna A, Piccinini P, Carta F. Effect of oral linoleic and γ-linolenic acid on meibomian gland dysfunction. Cornea 2007; 26: 260-264.
29. Mascai MS. The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction. Trans Am Ophthalmol Soc 2008; 106: 336-356.
30. Perry HD, Doshi-Carnevale S, Donnenfeld ED, Solomon R, Biser SA, Bloom AH. Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction. Cornea 2006; 25: 71-175.
31. Rubin M, Rao SN. Efficacy of topical Cyclosporin 0.05% in the treatment of posterior blepharitis. J Ocul Pharmacol Ther 2006: 22: 47-53.
32. Fiedlaender MH, Protzko E. Clinical development of 1% azithromycin in durasite, a topical azalide anti-infective for ocular surface therapy. Clin Ophthalmol 2007; 1: 3-10.
33. Amar T, Caillaud T, Elena PP. Ocular pharmacokinetic study following single and multiple azithromycin administrations in pigmented rabbits. Curr Eye Res 2008; 33: 149-158.
34. Ianaro A, Ialenti A, Maffia P, Sautebin L, Rombolà L, Carnuccio R, Iuvone T etal. Anti-inflammatory activity of macrolide antibiotics. J Pharmacol Exp Ther 2000; 292: 156-163.
35. Scaglione F, Rossoni G. Comparative anti-inflammatory effects of roxithromycin, azithromycin and clarithromycin. J Antimicrob Chemother 1998; 41: 47-50.
36. Aghai ZH, Kode A, Saslow JG, Nakhla T, Farhath S, Stahl GE, Eydelman R etal. Azithromycin suppresses activation of nuclear factor-kappa B and synthesis of pro-inflammatory cytokines in tracheal aspirate cells from premature infants. Pediatr Res 2007; 62: 483-488.
37. Li DQ, Zhou N, Zhang L, Ma P, Pflugfelder SC. Azithromycin suppresses Zymosan-induced production of pro-inflammatory mediators by human corneal epithelial cells. Invest Ophthalmol Vis Sci 2010 Jun 10. [Epub ahead of print]
38. Luchs J. Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis. Adv Ther 2008; 25: 858-870.
39. John T, Shah AA. Use of azithromycin ophthalmic solution in the treatment of chronic mixed anterior blepharitis. Ann Ophthalmol (Skokie) 2008; 40: 68-74.
40. Perry HD, Solomon R, Donnenfeld ED, Perry AR, Wottpenn JR, Greenman HE, Savage HE. Evaluation of topical cyclosporine for the treatment of dry eye disease. Arch Ophthalmol 2008; 126: 1046-1050.
41. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 2000; 118: 615-621.
42. Nicolaides N, Kaitaranta JK, Rowdah TN, Macy JI, Boswell FM, Smith RE. Meibomian gland studies: Comparison of steer and human lipids. Invest Ophthalmol Vis Sci 1981; 20: 522-536.
43. Shine WE, McCulley JP. Keratoconjunctivitis sicca associated with meibomian secretion polar lipid abnormality. Arch Ophthalmol 1998; 116: 849-852.
44. McCulley JP, Shine WE. Changing concepts in the diagnosis and management of blepharitis. Cornea 2000; 19: 650-658.
45. Zengin N, Tol H, Gunduz K, Okudan S, Balevi S, Endogru H. Meibomian gland dysfunction and tear film abnormalities in rosacea. Cornea 1995; 14: 144-146.
46. Protzko E, Bowman L, Abelson M, Shapiro A, AzaSite Clinical Study Group. Phase 3 safety comparisons for 1.0% azithromycin in polymeric mucoadhesive eye drops versus 0.3% tobramycin eye drops for bacterial conjunctivitis. Invest Ophthalmol Vis Sci 2007; 48: 3425-3429.
47. Lemp MA, Nichols KK. Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. Ocul Surf 2009 April 7; (2 Suppl): S1-S14.